arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

CHEMED CORP

CHE
$534.05 ▼ -14.76 (-2.69%) at close
Healthcare ·Services-Home Health Care Services ·USServices-Home Health Care Services
73 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
82
Health
Excellent
Bullish
auto_awesome

Analytical Summary

CHEMED CORP shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $7.0B
Dividend Yield 0.13%
Revenue Growth 10.6% ↗
Op. Margin 14.0% ↗
ROIC 6.5% ↘
FCF / Share $2.90 ↘
Trailing P/E 97.3x
Price / Book 8.1x
FCF Yield 0.5%
Debt / Equity 0.27
info Valuation on last close. End-of-day price, Nov 5, 2026.

73-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$690.94M
↑ +10.6% —
Net Income Profit after all expenses
$71.65M
↑ +11.5% —
Operating Margin Operating profit as % of sales
14.0%
↑ +5.3% 64th
FCF / Share Free cash flow per share
$2.90
↓ -44.9% —
Long-Term Debt Long-term obligations
$236.00M
↑ +68.6% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
66
Returns ↓
91
Financial Health ↑
96
Cash Quality ↑
74

Dividend History

Dividend / share · sourced from SEC filings
$2.20 Latest / share
+22.2% YoY
+9.1% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 19 years · 73 quarters